The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of olaparib and durvalumab in patients with IDH-mutated cholangiocarcinoma.
 
Erica S. Tsang
No Relationships to Disclose
 
Grainne M. O'Kane
Honoraria - AstraZeneca; Eisai; MSD Oncology; Roche
Consulting or Advisory Role - AstraZeneca Canada; Eisai; Incyte; Roche; Servier
Travel, Accommodations, Expenses - AstraZeneca/MedImmune
 
Jennifer J. Knox
Honoraria - AstraZeneca; Roche Canada
Consulting or Advisory Role - AstraZeneca/MedImmune; Incyte; Ipsen; Lilly; Merck
Research Funding - AstraZeneca; Ipsen; Merck
Expert Testimony - AstraZeneca
 
Eric X Chen
No Relationships to Disclose